SignatureFD
ABCL icon

SignatureFD’s AbCellera Biologics ABCL Stock Holding History

SignatureFD’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$149K Buy
10,240
+102
+1% +$968 ﹤0.01% 1327
2026
Q2 		$79.6K Buy
10,138
+899
+10% +$4.39K ﹤0.01% 1581
2026
Q1 		$32.2K Sell
9,239
-1,225
-12% -$4.41K ﹤0.01% 1965
2025
Q4 		$35.8K Sell
10,464
-1,986
-16% -$8.86K ﹤0.01% 1841
2025
Q3 		$62.6K Buy
12,450
+3,019
+32% +$13.3K ﹤0.01% 1522
2025
Q2 		$32.3K Sell
9,431
-7,016
-43% -$17.5K ﹤0.01% 1824
2025
Q1 		$36.7K Sell
16,447
-41,019
-71% -$118K ﹤0.01% 1745
2024
Q4 		$168K Buy
57,466
+21,807
+61% +$60.7K ﹤0.01% 947
2024
Q3 		$92.7K Buy
35,659
+25,294
+244% +$70.1K ﹤0.01% 1253
2024
Q2 		$30.7K Sell
10,365
-751
-7% -$2.84K ﹤0.01% 1756
2024
Q1 		$50.4K Buy
11,116
+520
+5% +$2.65K ﹤0.01% 1553
2023
Q4 		$60.5K Buy
10,596
+7,988
+306% +$37K ﹤0.01% 1374
2023
Q3 		$12K Sell
2,608
-807
-24% -$4.91K ﹤0.01% 2104
2023
Q2 		$22.1K Buy
3,415
+2,876
+534% +$19.6K ﹤0.01% 1838
2023
Q1 		$4.06K Buy
539
+80
+17% +$726 ﹤0.01% 2587
2022
Q4 		$4.65K Buy
459
+187
+69% +$2.16K ﹤0.01% 2508
2022
Q3 		$3K Buy
+272
New +$2.98K ﹤0.01% 2593

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
DKM Wealth Management
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
Lantern Wealth Advisors
Lantern Wealth Advisors Melville, New York $232M AUM 16.88% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Stone House Investment Management
Stone House Investment Management Tunkhannock, Pennsylvania $768M AUM 12.07% 1-Year Est. Return

SignatureFD's ABCL Position: Q3 2026 in Review

SignatureFD increased its AbCellera Biologics (ABCL) stake by 1% in Q3 2026, buying an estimated $968 and bringing the position to 10,240 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

SignatureFD first reported a position in ABCL in Q3 2022 and has held it in 17 quarters since. The position peaked at $168K in Q4 2024. 15 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • SignatureFD held 10,240 shares of AbCellera Biologics worth $149K as of Q3 2026.
  • SignatureFD bought 102 AbCellera Biologics shares in Q3 2026, an estimated $968.
  • AbCellera Biologics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1327 holding.
  • SignatureFD first reported a position in AbCellera Biologics in Q3 2022 and has held it in 17 quarters since.
  • SignatureFD's AbCellera Biologics position peaked at $168K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.